OSU masthead and toolbar

The Ohio State University
www.osu.edu
  1. Help
  2. Campus map
  3. Find people
  4. Webmail

onCampus--Ohio State's faculty/staff news

Vol. 38, No. 18


  1. onCampus Home

OSU LINKS

  1. OSUToday
  2. Faculty/Staff Page
  3. News & Information
  4. Research News
  5. Trustees
  6. OSU Home

1-9-2008
By:

Cancer positions realigned

Caligiuri to lead The James as the program looks ahead to the Med Center expansion
President E. Gordon Gee has announced two changes in leadership to Ohio State’s cancer program that he said will allow it to move swiftly toward its goal of becoming a top-10 National Cancer Institute-funded program and to focus efforts on planned expansion of the Medical Center.

In the restructuring, the leadership of the research and clinical components of the cancer program will be consolidated into one position, with Michael Caligiuri succeeding David Schuller as CEO of The James.

Schuller has been appointed vice president for Medical Center Expansion and Outreach by Wiley “Chip” Souba Jr., interim senior vice president and executive dean for Health Sciences and CEO of the Medical Center. Schuller will retain his position as medical director of the Medical Center’s development campaign, strengthening the university’s commitment to the planned Medical Center expansion and the importance of the cancer program to that $1 billion project.

“It is clear that the priorities and objectives of the cancer program are critical to achieving the goals of the Medical Center and University,” Gee said. “This new alignment puts two of our most talented cancer leaders in roles that give us the greatest potential and opportunities for accomplishing our mutual goals.”

Caligiuri, who will report to Gee, will be responsible for all administrative, financial and operational aspects of The James. He also will continue as director of the Comprehensive Cancer Center and in that capacity report to Joseph Alutto, university executive vice president and provost.

The position leverages Caligiuri’s expertise in medical research and the influence “bench to bedside” medical discoveries will have in the prevention and treatment of cancer.

Schuller will continue to work on the executive planning team for the Medical Center’s master facilities plan as it develops the new footprint for the larger and enhanced Medical Center scheduled for construction during the next five to seven years.

“There is no one more passionate about the expansion than David Schuller,” Caligiuri said. “To have him at the table, with that passion, is another great advantage for everyone as we take on this challenging project.”

In his 10 years at Ohio State, Caligiuri has played a critical role in the dramatic advancement of the cancer programs. In its most recent review by the NCI, the Comprehensive Cancer Center received the highest possible score and a $19.2 million grant renewal.

Schuller has dedicated his career to advancing the cancer program at Ohio State for more than 20 years. He will hold the title of CEO Emeritus of The James and Director Emeritus of the Comprehensive Cancer Center.

onCampus Home